The Acceptability of a Rapid Assessment of Esophageal Adenocarcinoma Risk Test (REACT)

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to evaluate the acceptability of a new non-invasive screening device to test for Barrett's esophagus. The investigators will prospectively enroll 100 patients to undergo Cytosponge testing. The time of involvement for an individual will range from 2 weeks to 2 months, depending on the results of the Cytosponge test and time to follow up endoscopy, if indicated.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 75
Healthy Volunteers: No
View:

• Males:

• Ages 50-75 and at least one of the following:

• Gastro-esophageal reflux disease (GERD)* or

• Family history (first degree relative) with Barrett's esophagus or esophageal adenocarcinoma or

• Both body mass index (BMI) ≥30 or

• A history of cigarette smoking (at least 10 pack years)

• Females:

• Ages 50-75 and GERD* and at least one of the following:

• Family history (first degree relative) with Barrett's esophagus or esophageal adenocarcinoma or

• BMI ≥30 or

• A history of cigarette smoking (at least 10 pack years)

Locations
United States
New York
Columbia University Irving Medical Center
Recruiting
New York
Contact Information
Primary
Katharine Boyce
kb3217@cumc.columbia.edu
212-305-9541
Time Frame
Start Date: August 1, 2018
Estimated Completion Date: December 2023
Participants
Target number of participants: 100
Treatments
Other: Cytosponge Test
This arm will include individuals without formal diagnosis of Barrett's esophagus.
Authors
Charles Lightdale, Antonia Sepulveda, Julian Abrams, Patricia Tiscornia-Wasserman
Sponsors
Leads: Columbia University

This content was sourced from clinicaltrials.gov